Feltl & Co Downgrades Insulet Corporation (PODD) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
UPDATE: Northland Capital Markets Upgrades Insulet Corporation (PODD) to Outperform
May 4, 2015 7:27 AM EDT(Updated - May 4, 2015 8:43 AM EDT)
Northland Capital Markets upgraded Insulet Corporation (NASDAQ: PODD) from Market Perform to Outperform with a price target of $32. Analyst Suraj Kalia sees short-term risk to numbers but he is positive overall given recent under-performance.
"Overall, we... More
Insulet Corp. (PODD) Misses Q1 EPS by 1c, Offers Q2, FY Rev. Guiance
April 30, 2015 4:14 PM EDTInsulet Corp. (NASDAQ: PODD) reported Q1 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $61.2 million versus the consensus estimate of $68.2 million.
Insulet Corp. sees FY2015 revenue of $305-320 million, versus the consensus of $312.57... More
